- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
38 Cards in this Set
- Front
- Back
|
diagnosis of chronic kidney disease
|
reduction of GFR <60 for 3 or more months that is damaging (structural or functional) the kidney; progressive and irreversible loss of renal function
|
|
diagnosis of ESRD
|
GFR <15; stage V of kidney disease; need renal replacement therapy (dialysis or transplant)
|
|
diagnosis of ARF
|
any of the following that happens abruptly within 48 hours: 1) absolute increase in serum Cr of > or equal to .3 mg/dL; 2) percentage increase of > or equal to 50% (relative increase of serum creatinine level); reduction in urine output (oliguria <.5mL/kg/hr for >6 hrs)
|
|
lab results of CKD
|
elevated BUN and Cr; hyperkalemia; elevated PTH (secondary hyperparathyroidism); hyperphosphatemia; hyponatremia; hypocalcemia; low Hgb; low albumin; low GFR; metabolic acidosis
|
|
medical conditions in which pts can have CKD without decreased kidney size on US
|
multiple myeloma and DM
also polycystic kidney disease, HIV-associated nephropathy, amyloidosis, obstructive uropathy |
|
2 most common causes of CKD
|
DM (leading cause of ESRD) and HTN (next highest cause)
|
|
physiology behind secondary hyperparathyroidism
|
when the kidney function goes down, it can't excrete phosphate properly so this leads to hyperphosphatemia; the excess phosphate leads to low calcium which stimulates the parathyroid to release more PTH, the excess PTH leads to calcium leaching from the bones, the calcium leaching leads to bone changes like osteodystrophy
|
|
S/S for uremia
|
refers to s/s associated with accumulation of nitrogenous wastes due to impaired to renal function-- usually don't appear until BUN >60; decreased attentiveness, N/V, anorexia, taste changes, weight change, dyspnea, orthopnea, leg swelling, fatigue, bone pain/fractures, muscle cramps, muscle weakness, restless legs, peripheral neuropathy, pruritis, urinary urgency, urinary frequency, nocturia, dysuria
|
|
PE for uremia
|
height, weight, orthostatic vital signs, volume assesment (rales, JVD, peripheral edema, cardiac gallop/rub), vascular exam (pulses, bruits), abdominal exam (mass, bruit, palpable bladder, flank tenderness), DRE (prostate), Neurologic exam, skin exam (look for uremic frost), smell breath (uremic fetor), joint exam
|
|
who needs dialysis
|
stage 5 and ALL uremic pericarditis pts; need to get access (AV fistula) in stage 4
|
|
what medications can falsely elevate serum Cr without ARF
|
cimetidine (tagamet) and sulfa drugs like Bactrim
|
|
treatment goals for CKD
|
therapy based on stage of CKD, management of underlying conditions!!!!, interventions to slow progression of CKD, reduction of CV risk factors, treatment of complications, preparation for kidney failure and kidney replacement therapy
|
|
what do you do at every visit of someone with CKD
|
medication review at all visits!-- dosage adjustments, detection of drug interactions, therapuetic drug monitoring if possible, id potentially adverse effects on kidney function
|
|
what's gonna happen when you start an ACE-I
|
15-30% rise in serum creatinine, then they typically will return to baseline in 4-6 weeks, can generally continue therapy as long as GFR doesn't rise more than 30%
|
|
starting Beta-blockers in CKD pts
|
use liver metabolized ones whenever possible (metoprolol, propanolol, labetalol, carvedilol)-- no renal adjustment necessary. Hydrophilic ones need dose adjustments
|
|
CCBs in CKD
|
diltiazem and verapamil may help but not nifedipine and amlodipine (can make proteinuria worse)
|
|
analgesics in CKD
|
acetaminophen generally considered safe (metabolized by the liver); other analgesics like demerol, darvon, morphine, tramadol, and cocaine should not be used in stage 4 or 5 CKD bc metablolites may accummulate causing CNS and respiratory adverse effects; also need dosing adjustment for CKD stage 2 and 3; avoid extended release ultram in CKD pts stage 3, 4, and 5
|
|
NSAIDs in CKD
|
short-term use ok as long as well-hydrated and renal function is ok (no CHF, DM, or HTN); AE: HYPERKALEMIA (can make it worse than it already was), peripheral edema, higher blood pressure, decompensation of CHF, risk of ARF 3x higher
|
|
stage I CKD
|
kidney damage with normal or increased GFR: >90
|
|
stage II CKD
|
kidney damage with mild decrease in GFR (60-89)
|
|
stage III CKD
|
moderate decrease of GFR (30-59)
|
|
stage IV CKD
|
severe loss of GFR (15-29)
|
|
stage V CKD
|
kidney failure (<15 or dialysis)
|
|
monitoring/treatment of CKD stage I
|
monitor GFR annually, smoking cessation, ECASA 81mg po daily, ACE-I and/or ARB, BP goal (<130/80), LDL-C goal <100
|
|
managing adults with CKD stage II
|
same as stage I, consider nephrology referral if GFR declines >4 mL/min/year, evaluation by renal nutritionist (specific recommendations on protein, salt, water, potassium, and phosphorus intake)
|
|
managing CKD stage 4
|
everything previously stated plus consult nephrology, referral for vascular access, CKD patient education classes
|
|
managing CKD stage 5
|
renal replacement therapy, not a cure, treatment of chronic condition, hemodialysis-- vascular access before need arise, peritoneal dialysis possible, transplant= best solution but not a cure, better survival
|
|
markers of mortality and morbidity in ESRD
|
nutritional status: albumin (low), pre-albumin, creatinine (high)
|
|
most common etiology of hyperkalemia
|
metabolic acidosis
|
|
relationship between CKD and CAD
|
a person with CKD is 70% more likely to develop CAD
|
|
relationship between CKD and CHF
|
a person with CKD is 2 to 3x more likely to develop CHF
|
|
relationship between CKD and TIA/CVA
|
a person with CKD is 74% more likely to develop TIA/CVA
|
|
in a pt with normal kidneys, if he has an MI what will happen to CKMB and serum Cr
|
CKMB will go up, serum Cr will be normal (the kidneys aren't affected)
|
|
goal of LDLs and triglycerides for people with CKD
|
LDLs <100, triglyceride level <200
|
|
how often should you counsel a pt with CKD to stop smoking
|
every visit
|
|
2 estimators of GFR
|
Cockcroft-Gault ad MDRD (used at LSU, preferred-best available)
|
|
who are the GFR estimators not accurate for
|
overweight, underweight, children, extremes in muscle mass or nutritional status
|
|
anemia of CKD
|
have to work it up, can't assume it is related to kidneys, will be normocytic/normochromic; consider EPO treatment if uncorrected with Fe replacement (Hgb <10); monitor risks of thrombotic embolism
|